Low-frequency Transcranial Magnetic Stimulation To Enhance Motor Recovery In The Subacute Phase After Stroke
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 34
- 试验地点
- 2
- 主要终点
- Motor function of the paretic hand evaluated with the Jebsen-Taylor test
研究概览
简要总结
Low-frequency repetitive transcranial magnetic stimulation (rTMS) of the unaffected hemisphere (UH) transiently improves motor function in patients in the chronic phase after stroke. The goal of this study is to investigate effects on motor recovery of low-frequency rTMS of the UH, administered in the subacute phase after stroke.
详细描述
Stroke is a major cause of disability and worldwide. Hand motor impairment is frequent after stroke. Even mild impairments of the upper limb negatively impact disability and quality of life in these patients significantly contributes to disability. Therapeutic alternatives for hand motor rehabilitation are deeply needed.
Repetitive transcranial magnetic stimulation (rTMS) has emerged as a potential tool to improve hand motor performance after stroke. While high-frequency rTMS (HF-rTMS) often increases motor cortical excitability, LF-rTMS often has the opposite effect. Up-regulation of excitability in the affected hemisphere by HF-rTMS or down-regulation of the UH by LF-rTMS can restore the balance in inter-hemispheric inhibition and hence, facilitate movement of the paretic hand Both strategies, as well as the combination of both, have yielded encouraging results when applied in proof-of-principle, single-session studies to patients with mild hand motor impairment in the subacute and chronic stages after stroke. However, few rTMS studies included patients less than six months after stroke, and effects of LF-rTMS of the unaffected hemisphere in patients with severe motor impairment in the subacute phase have not been yet reported.
The investigators opted for a novel approach to enhance hand motor recovery, by examining feasibility, safety and preliminary efficacy of either active or sham LF-rTMS of the UH or sham rTMS as add-on therapies to outpatient customary rehabilitation, to patients with mild to severe hand paresis, within 5-45 days after unilateral ischemic stroke. The investigators hypothesize that, at this stage, LF-rTMS will be feasible even in patients with severe motor deficits, will have minimal adverse events and will enhance effects of customary rehabilitation on hand motor performance.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Care Provider, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •First-ever ischemic stroke in the internal carotid artery territory confirmed by CT or MRI, 5-45 days before, leading to contralateral hand weakness
- •Age, 18-80 years
排除标准
- •Cardiac pacemaker
- •Pregnancy
- •Implantable medication pump
- •Intracranial hypertension
- •History of seizures
- •Metal in the head
- •Decompressive surgery
- •Other neurological diseases
- •Shoulder pain
- •Joint deformity in the paretic upper limb
- •Severe chronic disease such as end-stage cancer or end-stage renal failure
- •Inability to provide informed consent due to severe language or cognitive impairment
研究组 & 干预措施
Active rTMS
1Hz active rTMS delivered to the unaffected hemisphere
干预措施: Repetitive transcranial magnetic stimulation (Other)
Placebo rTMS
1Hz placebo rTMS delivered to the vertex
干预措施: Repetitive transcranial magnetic stimulation (Other)
结局指标
主要结局
Motor function of the paretic hand evaluated with the Jebsen-Taylor test
时间窗: Baseline, two weeks, 1 month, 3 and six months after end of treatment
Number of Participants with Adverse Events as a Measure of Safety and Tolerability
时间窗: Baseline, two weeks, 1 month, 3 and six months after end of treatment
Number of patients able to comply with the protocol
时间窗: Baseline, two weeks, 1 month, 3 and six months after end of treatment
次要结局
- Force of the paretic hand(Baseline, two weeks, 1 month, 3 and six months after end of treatment)
- Disability evaluated with the modified Rankin scale(Baseline, two weeks, 1 month, 3 and six months after end of treatment)
- Functional Independence Measure(Baseline, two weeks, 1 month, 3 and six months after end of treatment)
- Fugl-Meyer evaluation of motor performance (upper limb)(Baseline, two weeks, 1 month, 3 and six months after end of treatment)
- Neurological impairment evaluated with the NIH Stroke Scale(Baseline, two weeks, 1 month, 3 and six months after end of treatment)
- Measures of corticomotor excitability evaluated with transcranial magnetic stimulation(Baseline, two weeks, 1 month, 3 and six months after end of treatment)
研究者
Adriana Bastos Conforto
Professor and Neurologist, Neurostimulation Laboratory
University of Sao Paulo General Hospital